Black Diamond Therapeutics (BDTX) Other Non Operating Income (2019 - 2021)
Historic Other Non Operating Income for Black Diamond Therapeutics (BDTX) over the last 3 years, with Q4 2021 value amounting to -$375000.0.
- Black Diamond Therapeutics' Other Non Operating Income rose 4619.8% to -$375000.0 in Q4 2021 from the same period last year, while for Dec 2021 it was -$2.1 million, marking a year-over-year decrease of 2684.8%. This contributed to the annual value of -$2.2 million for FY2021, which is 2691.42% down from last year.
- Latest data reveals that Black Diamond Therapeutics reported Other Non Operating Income of -$375000.0 as of Q4 2021, which was up 4619.8% from -$489000.0 recorded in Q3 2021.
- Black Diamond Therapeutics' Other Non Operating Income's 5-year high stood at $23000.0 during Q4 2019, with a 5-year trough of -$5.3 million in Q2 2019.
- Over the past 3 years, Black Diamond Therapeutics' median Other Non Operating Income value was -$584000.0 (recorded in 2021), while the average stood at -$1.1 million.
- Examining YoY changes over the last 5 years, Black Diamond Therapeutics' Other Non Operating Income showed a top increase of 9201.89% in 2020 and a maximum decrease of 313043.48% in 2020.
- Over the past 3 years, Black Diamond Therapeutics' Other Non Operating Income (Quarter) stood at $23000.0 in 2019, then tumbled by 3130.43% to -$697000.0 in 2020, then surged by 46.2% to -$375000.0 in 2021.
- Its Other Non Operating Income stands at -$375000.0 for Q4 2021, versus -$489000.0 for Q3 2021 and -$584000.0 for Q2 2021.